Six2 and Wnt Regulate Self-Renewal and Commitment of Nephron Progenitors through Shared Gene Regulatory Networks by Park, Joo-Seop et al.
Six2 and Wnt regulate self-renewal and commitment of nephron
progenitors through shared gene regulatory networks
Joo-Seop Park1,3,*, Wenxiu Ma2, Lori L. O’Brien3,9, Eunah Chung1, Jin-Jin Guo3,9, Jr-Gang
Cheng4, M. Todd Valerius5,8, Jill A. McMahon3,9, Wing Hung Wong6, and Andrew P.
McMahon3,7,8,9,*
1Divisions of Pediatric Urology and Developmental Biology, Cincinnati Children’s Hospital Medical
Center, Cincinnati, OH 45229, USA
2Department of Computer Science, Stanford University, Stanford, CA 94305, USA
3Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138,
USA
4UNC-Neuroscience Center, University of North Carolina School of Medicine, Chapel Hill, NC
27599, USA
5Department of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA
02115, USA
6Departments of Statistics and Health Research and Policy, Stanford University, Stanford, CA
94305, USA
7Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA
8Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA
SUMMARY
A balance between Six2-dependent self-renewal and canonical Wnt signaling-directed
commitment regulates mammalian nephrogenesis. Intersectional studies using chromatin
immunoprecipitation and transcriptional profiling identified direct target genes shared by each
pathway within nephron progenitors. Wnt4 and Fgf8 are essential for progenitor commitment; cis-
regulatory modules flanking each gene are co-bound by Six2 and β-catenin, and dependent on
conserved Lef/Tcf binding sites for activity. In vitro and in vivo analyses suggest that Six2 and
Lef/Tcf factors form a regulatory complex that promotes progenitor maintenance while entry of β-
catenin into this complex promotes nephrogenesis. Alternative transcriptional responses associated
with Six2 and β-catenin co-binding events occur through non-Lef/Tcf DNA binding mechanisms
highlighting the regulatory complexity downstream of Wnt signaling in the developing
mammalian kidney.
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Assembly of the mammalian kidney is driven by epithelial-mesenchymal interactions
between stem/progenitor cells within the ureteric epithelium and the adjacent cap
mesenchyme (CM) (Costantini and Kopan, 2010; Dressler, 2009). GDNF and FGF signals,
predominantly secreted by the CM, induce repetitive branching of the ureteric epithelium
elaborating the renal collecting duct network (Sánchez et al., 1996; Moore et al., 1996; Vega
et al., 1996; Michos et al., 2010). In contrast, Wnt9b secreted by the ureteric epithelium
induces CM progenitors to transition to epithelial renal vesicles (RVs), each RV giving rise
to a single nephron (Carroll et al., 2005).
Progenitors located adjacent to the medullary face of branch tips cluster to form pretubular
aggregates before transitioning to epithelial RVs whereas those in the outermost kidney
cortex remain undifferentiated. Importantly, the maintenance of CM progenitors ensures
continued ureteric branching through the production of branching factors, and the cellular
template for new waves of nephrogenesis until the progenitor population is exhausted in the
prenatal or early postnatal period.
Nephron progenitors express the transcriptional regulator Six2 (Kobayashi et al., 2008). The
Six2+ population comprises self-renewing, multi-potent nephron progenitors, and Six2 is
essential for maintaining the progenitor state; CM prematurely undergoes an ectopic
mesenchymal to epithelial transition (MET) in Six2 mutants, rapidly depleting the nephron
progenitors (Self et al., 2006; Kobayashi et al., 2008). Normal nephrogenesis and ectopic
nephrogenesis in Six2 mutants require a Wnt9b signal from the ureteric epithelium (Carroll
et al., 2005; Kobayashi et al., 2008). A second Wnt-family member, Wnt4, and an FGF
family member, Fgf8, act downstream of Wnt9b in the transition of induced CM to RVs
(Stark et al., 1994; Grieshammer et al., 2005; Perantoni et al., 2005). Canonical Wnt
signaling directed by β-catenin is necessary and sufficient to mediate the essential early
inductive actions of Wnt9b and Wnt4, though Wnt4 likely utilizes an alternative mechanism
in the final phase of epitheliarization (Park et al., 2007; Tanigawa et al., 2011; Burn et al.,
2011). Although Wnt/β-catenin and Six2 pathways have opposing actions, commitment and
self-renewal of progenitors, respectively, recent studies also suggest Six2 and Wnt9b
collaborate at some level in maintaining expression of a subset of CM-specific genes
(Karner et al., 2011).
Here, we identified a prominent set of cis-regulatory modules (CRMs) co-bound by both
Six2 and β-catenin containing transcriptional complexes. A functional analysis of CRMs and
regulatory transcriptional complexes provide evidence for both opposing and collaborative
interactions between Six2 and Wnt-driven regulatory programs through distinct DNA-
binding mechanisms at shared enhancers within the nephron progenitor population.
RESULTS
Transient activation of canonical Wnt signaling induces MET within isolated Six2+
nephron progenitor cells
We previously showed that expression of a dominant active form of β-catenin in nephron
progenitors induces ectopic expression of early markers of nephrogenesis including Fgf8
and Wnt4. However, induced cells retained a mesenchymal phenotype, failing to transition
to an E-cadherin producing renal epithelium (Park et al., 2007). In contrast, transient
elevation of β-catenin levels and canonical Wnt pathway activity through pharmacological
suppression of glycogen synthase kinase-3 (GSK3) with BIO (6-bromoindirubin-3’-oxime;
Meijer et al., 2003) within isolated kidney mesenchyme – a heterogeneous population
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comprising nephron, interstitial, and vascular progenitors - stimulates the MET of induced
nephron progenitors (Kuure at al., 2007).
To determine the specific action of BIO-directed canonical Wnt pathway activation on
isolated nephron progenitors, we used fluorescence-activated cell sorting (FACS) to isolate
Six2 progenitors from mice expressing a GFP transgene under Six2 regulatory control
(Kobayashi et al., 2008). When Six2+ progenitors were aggregated and cultured for 48
hours, the first 24 hrs in BIO supplemented medium, the second 24 hrs in vehicle carrier
(DMSO), progenitors activated E-cadherin (Figure 1A) and a post-epithelial specific tubule
marker, Jag1 (data not shown). When Six2+ progenitors were cultured continuously in BIO
(Figure 1A), or in dispersed culture with transient exposure to BIO (Figure S1), Six2+ cells
failed to activate E-cadherin. Thus, a transient elevation of β-catenin levels within isolated,
aggregates of Six2+ progenitor cells, in the absence of other cellular inputs, is sufficient to
initiate the induction of nephrogenesis mirroring the normal action of Wnt9b in the
mammalian kidney. Quantitative analysis of expression markers suggests that there is no
substantial change in cell number in DMSO or BIO treated populations over 24 hrs (data not
shown).
To examine the global transcriptional changes occurring on Wnt pathway activation, Six2+
progenitor aggregates were incubated with BIO and examined by transcriptional profiling.
Figure 1B highlights a selected subset of key genes whose expression and activity is linked
to the regulation of kidney development; a detailed analysis of the transcriptional responses
is presented in Table S1. As expected, markers of the CM, including Six2, Meox2, and Eya1,
were highly expressed in freshly isolated nephron progenitors. Interestingly, Six2 and Meox2
showed significantly lower expression levels in BIO versus DMSO treated control
aggregates, consistent with canonical Wnt signaling antagonizing their expression. In
contrast, Eya1, a gene essential for appropriate specification of the metanephric
mesenchyme in the kidney anlagen (Xu et al., 1999; Sajithlal et al., 2005), showed elevated
levels in BIO treated samples at 24 hrs suggesting a positive role for canonical Wnt
signaling in maintaining normal levels of this regulatory factor within the CM.
Axin2 and Sp5, broad targets of canonical Wnt signaling in multiple tissue types, and Wnt4,
a specific transcriptional readout of a Wnt9b-dependent nephrogenic response, showed a
strong activation in BIO treated cells independent of cell density at 24 hrs (Figure 1B).
However, expression of most early nephrogenic inductive markers including Fgf8
(Grieshammer et al., 2005; Perantoni et al., 2005), Pax8 (Carroll et al., 2005), Bmp2
(Georgas et al., 2009), Bmp7 (Dudley et al., 1995), and Cxcr4 (Ueland et al., 2009) was only
observed in aggregate cultures highlighting the importance of cell density dependent
interactions in the inductive response. Expression of these genes was maintained on
extension of BIO treatment for an additional 24 hrs whereas the withdrawal of BIO resulted
in a downregulation of general Wnt targets, and the activation of E-cadherin (Cdh1) and a
number of Notch pathway components (Notch1, Hes5, and Dll1), consistent with an
epithelial transition and the initiation of proximal nephron patterning pathways, respectively,
on transient Wnt signaling in Six2 progenitors (Chen and Al-Awqati, 2005; Cheng et al.,
2007).
In summary, the in vitro BIO-mediated model of Six2-GFP+ cells replicates many features
of the in vivo Wnt-mediated induction of Six2+ cells. Further, the in vitro data provides
evidence for additional roles for β-catenin action, and potentially canonical Wnt signaling, in
both abrogating (Six2) and supporting (Eya1) expression of key regulatory factors within the
CM. Finally, 80% of the genes reported downregulated in CM of Wnt9b mutants at E11.5
(Karner et al., 2011) were up regulated on BIO treatment of FACS isolated Six2 cells at
E16.5, in good agreement with a Wnt9b-driven canonical Wnt pathway (Table S1).
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Differences between the data sets may reflect temporal differences in the cellular responses
or the modifying role of other cell-types present in the E11.5 kidney analysis.
Genomic mapping of β-catenin and Six2 binding sites in nephron progenitor cells
Canonical Wnt signaling is mediated by four Lef/Tcf family members: each member is
reported to generate multiple protein isoforms (Arce et al., 2006). Lef/Tcf factors associate
with DNA targets in repressive complexes independent of Wnt signaling. High quality
antibodies with broad specificity for all isoforms of each Lef/Tcf factor have not been
described. In order to identify direct transcriptional targets specific to a Six2-mediated
pathway of nephron progenitor maintenance and a canonical Wnt pathway driven program
of nephron induction, we isolated Six2-GFP+ nephron progenitors by FACS and examined
Six2 and β-catenin association with DNA targets by chromatin immunoprecipitation (ChIP)
and high-throughput DNA sequencing (ChIP-seq).
At a False Discovery Rate (FDR) of 0.01, we detected 569 β-catenin ChIP peaks and 1359
Six2 ChIP peaks using a two-sample iterative peak caller (Ma and Wong, 2011) (Figure 2A
and Table S2). Analysis of the distribution of peaks showed that Six2 bound peaks generally
lie closer to the transcriptional start site (TSS) of the nearest gene than those bound by β-
catenin (Figure 2B). When compared to 10,000 random control regions, Six2 peaks are
significantly enriched in 5’ UTR regions (p-value, 7.6E-19), intron regions (p-value,
2.8E-19), and 1 kb upstream regions (p-value, 1.8E-60) while β-catenin peaks are enriched
in intronic regions (p-value, 3.8E-3) (Table S2).
Interestingly and unexpectedly, 130 (22.84%) of the β-catenin peaks overlapped with Six2
peaks (9.57%; Figure 2A and Table S2), a significant result (p-value <1E-360). A number of
other β-catenin associated sites showed statistically significant binding in only one
biological replicate of the Six2 ChIP, but a clear trend of Six2 association in the weaker
sample. Estimating that only 1.0% of the genome of mouse kidney cells is accessible for
transcription factor binding (Song et al., 2011), the intersection of β-catenin and Six2 peaks
was highly significant (p-value, <1E-156).
To further annotate and assign potential function to β-catenin, Six2, and co-bound DNA
regions, a GREAT (Genomic Region Enrichment of Annotation Tool) analysis (McLean et
al., 2010) was performed on each data set (Figure 2F, Table S2). The recovery of anatomical
annotation terms in each grouping shows a strong association with the target tissue (Figure
2F). Analysis of Gene Ontology (GO) Biological Processes shows a correlation for all
groupings with processes involving development and morphogenesis, with enrichments in
co-bound regions for kidney and renal system development (Table S2). All regions also
show strong correlations with genes related to kidney specific phenotypes, such as abnormal
kidney development and renal hypoplasia (Table S2). These data indicate that Six2 and β-
catenin bind near and regulate expression of genes that are necessary for proper kidney
development.
De novo motif analysis uncovers Tcf, Six2, and Hox motifs in β-catenin and Six2 bound
regions
To understand the interplay between β-catenin and Six2, and to identify other regulatory
factors that may collaborate in protein-DNA interactions, de novo motif recovery was
performed on β-catenin binding regions, Six2 binding regions, and co-bound regions,
separately, using the CisGenome package (Ji et al., 2008). Five de novo motifs were
significantly enriched in our peak sets (Figure 2C). These motifs were compared with
TRANSFAC (TRANScription regulatory FACtors) (Matys et al., 2003) and UniProbe
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(Universal PBM Resource for Oligonucleotide-Binding Evaluation) (Badis et al., 2009;
Berger et al., 2008) databases, and data in the literature.
The most enriched motif in the β-catenin peak dataset is highly related to the Lef/Tcf
prediction in the TRANSFAC and UniProbe databases. In contrast, the predicted de novo
Six2 motif does not match any known motif in the TRANSFAC database, and differs from
the motif identified in microarray binding studies (Berger et al., 2008) but matches a verified
Six2 motif within a regulatory region proximal to the Six2 promoter (Brodbeck et al., 2004,
Figure S2). We examined Six2 binding to these motifs by electrophoretic mobility shift
assays (EMSA). Strong Six2 binding was observed to the recovered predicted Six2 motif,
and binding was not effectively competed by the Six2 motif predicted though protein-DNA
microarray studies (Figure S2). Thus, the de novo Six2 motif recovered here likely
represents a genuine target site for Six2 interaction in vivo.
The de novo Tbp/Hox motif is similar to the TRANSFAC TBP motif and almost identical to
the published Hoxc9 motif recovered from ChIP-seq analysis of ES-cell derived motor
neurons (Jung et al., 2010). The de novo Ipf/Hox motif is similar to the TRANSFAC Ipf and
UniProbe Hoxc9 motif predictions. The recovery of Hox motifs in our ChIP-seq data
suggests that Hox factors are likely an additional component within the gene regulatory
networks of a set of Six2/β-catenin targets, consistent with genetic analysis illustrating a
critical role for Hox11 paralogs in kidney development (Wellik et al., 2002).
Of the β-catenin bound peak regions, 380 out of 569 (66.78%) were predicted to encode at
least one Lef/Tcf site, a highly significant enrichment over matched control regions (p-value
<1E-149), consistent with Lef/Tcf family members acting as the primary binding partners
for β-catenin (Figure 2D). In addition, 38.14%, 39.02%, and 30.03% of the β-catenin peaks
contain predicted Six2, Tbp/Hox, and Ipf/Hox motifs, respectively. 60-65% of β-catenin
peaks with a Six2, Tbp/Hox or Ipf/Hox motif are also predicted to contain a Lef/Tcf motif
(Figure 2D). The de novo Six2 motif is the most significantly enriched motif in the Six2
ChIP-seq peak regions (p-value <1E-595): 1116 (82.12%) of the 1359 Six2 peak regions
contain the recovered Six2 motif sites, a significantly higher frequency than that observed
for Lef/Tcf (25.39%; p-value for enriched occupancy in data set, <1E-3), Tbp/Hox motif
(36.72%; p-value for enriched occupancy in data set, <1E-35), or Ipf/Hox motif (29.07%; p-
value for enriched occupancy in data set, <1E-27) predictions (Figure 2E). A similar
percentage of Lef/Tcf (81.74%), Tbp/Hox (76.95%) and lpf/Hox (81.27%) recovered motif
containing peaks also contain the recovered Six2 motif (Figure 2E). Taken together, these
observations suggest potential interactions among β-catenin, Six2, Lef/Tcf, and Hox family
members to regulate self-renewal and differentiation of nephron progenitors.
Identification of direct targets of Six2 and β-catenin during early nephrogenesis
To examine the relationship between Six2 and β-catenin binding and gene expression
changes in response to BIO treatment, we identified the nearest neighboring gene to each
ChIP region for each data set, then intersected these genes with those displaying BIO-
dependent expression changes on in vitro culture of the Six2+ nephrogenic compartment
(Table S3). To access the significance of the association between Six2 and β-catenin binding
and the expression patterns of the target genes, we randomly selected 10,000 regions from
the genome as the control, and calculated the p-value of enrichment using one-proportion z-
test. For Six2, 693 peaks associated with genes whose expression decreased when
aggregated progenitor cultures treated with BIO for 24 hrs were compared to freshly sorted
cells (p-value for enrichment <1E-71); while 193 of the β-catenin bound regions mapped to
neighboring genes that showed elevated expression when BIO treated aggregates were
compared to control DMSO cultures (p-value for enrichment <1E-48). In addition, we also
observed a significant correlation of β-catenin binding about genes whose expression
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decreased on culture in BIO when compared with the starting population (237 binding
regions; p-value for enrichment <1E-10). Thus, β-catenin has a strong association with
distinct transcriptional outcomes within the Six2+target population.
To functionally interrogate putative CRMs predicted by Six2 and β-catenin ChIP-seq, we
focused on the subset of co-bound regions that lie adjacent to genes encoding three key
signaling factors whose expression was modified by BIO treatment (Figure 3 and Table S3).
Fgf8 and Wnt4 are essential for the transition of pretubular aggregates to RVs and are
amongst the earliest responses to ureteric Wnt9b signaling (Grieshammer et al., 2005;
Perantoni et al., 2005; Stark et al., 1994; Carroll et al., 2005). Bmp7 is expressed in the CM,
differentiating nephron progenitors, and the ureteric epithelium (Dudley et al., 1997; Godin
et al., 1998). Loss of Bmp7 results in a complex phenotype part of which reflects the failure
to maintain nephron progenitors (Dudley et al., 1995, 1999; Blank et al., 2009).
Table S4 shows the position of co-bound regions relative to the transcriptional start site
(TSS) of the nearest target genes showing a BIO-dependent increase in expression within
Six2+ aggregate cultures. Each binding region overlies a conserved block of DNA, a
considerable distance from the TSS of the putative target gene. In the case of Fgf8, binding
was localized within the intron of Fbxw4, a gene displaying weak, non-specific expression
unaltered by BIO treatment (data not shown). Interestingly, deletions and duplications
within intronic regions of Fbxw4 are associated with split-hand/foot malformation 3
(SHFM3), a human disease whose phenotypes correlate closely with Fgf8-dependent
developmental processes (Sidow et al., 1999; Friedli et al., 2008). Together these data are
consistent with a cis-regulatory action of these intronic regions on Fgf8 transcription.
To examine the regulatory activity of conserved blocks of DNA incorporating the identified
Six2/β-catenin binding regions, DNA fragments were tested for cis-regulatory activity in the
E15.5 mouse kidney (Table S4). Test regions comprising the conserved block of DNA that
incorporates the binding regions were cloned upstream of a minimal promoter driven-lacZ
reporter cassette and reporter expression was examined in G0 transgenic embryos (Figure 4).
Each of the three putative CRMs supported robust, reproducible, transgene expression in
over 50% of G0 transgenic embryos within the RV and RV derivatives (Figure 4A-C). To
verify transgene expression in early Wnt-induced derivatives of the Six2 population, we
compared expression of each transgene with Six2, and Jag1, a marker of differentiating RV
derivatives. Six2 was highly expressed in the CM and downregulated when nephron
progenitors aggregated on Wnt9b induction, persisting transiently in the proximal region of
the early RV (Figure 4D and 4E). As previously reported (Georgas et al., 2009), Jag1 was
detected in the distal region of the newly formed RV (Figure 4E), expression resolving to
the mid-segment of the S-shaped body during later stages of tubule development (Figure 4F
and 4G). The three putative CRMs about Fgf8, Wnt4 and Bmp7 showed similar reporter
gene expression in distal regions of the RV-derivative overlapping Jag1 (Figure 4H-M).
Expression at later S-shaped body stages remained distally restricted; in contrast, Jag1
expression was confined to the mid-section at these stages. In summary, transgene
expression in the RV is polarized at the outset of RV formation, consistent with reported
polarized expression of Fgf8 (Grieshammer et al., 2005) and Wnt4 (Georgas et al., 2009;
Mugford et al., 2009). Similar overall findings were obtained for conserved co-bound
regions adjacent to Cxcr4, a gene linked to kidney development (Takabatake et al.,
2009;Ueland et al., 2009) (Figure S3).
As discussed earlier, β-catenin does not bind directly to DNA but complexes with Lef/Tcf
family members to activate transcription of target genes in a canonical Wnt signaling
response. A strong Lef/Tcf binding motif was recovered through de novo motif discovery of
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β-catenin bound DNA regions (Figure 2C). To address the role of Lef/Tcf interactions, we
mutated conserved Lef/Tcf motifs in each of the CRMs associated with Wnt4, Fgf8, and
Bmp7: a single motif in Fgf8 and Bmp7 regulatory elements, and paired motifs for Wnt4
(Table S4). In each case, three-base changes in the core Lef/Tcf binding region (CTTTG >
ATGGG) abolished binding of TCF4B to its target site in EMSA assays (Figure S2), and led
to the complete loss of enhancer activity of each of the CRMs in the kidneys of transgenic
mice (Figure 4A-C). In addition, we mutated a conserved Six2 motif in the CRM associated
with Wnt4 to address the role of Six2. Seven out of 12 transgenic kidneys showed transgene
expression (data not shown). Of these, six showed expression within the RV derivatives
while two of the six also showed weaker broader expression throughout the kidney. The
seventh was ectopically activated within the interstitial mesenchyme progenitors. These
results contrast with five of six transgenics expressing the reporter under the control of the
wild-type Wnt4 enhancer element all of which displayed a RV derivative restricted pattern.
The variable results on mutation of this sequence may reflect more complex interactions
than simply the loss of a Six2 regulatory input.
In summary, each target shows BIO-dependent activation in vitro and Wnt9b-dependent
activation in vivo within differentiating Six2 derivatives (Carroll et al., 2005). The putative
enhancers drive reporter gene expression specifically within the RV. Whereas the putative
targets are expressed in other kidney compartments, only the RV derivative is labeled as
expected. Enhancer activity was dependent on evolutionary conserved Lef/Tcf binding sites
in each enhancer, consistent with β-catenin acting in conjunction with Lef/Tcf factors in a
conventional, canonical Wnt signaling pathway. Thus, each tested CRM likely mediates a
component of the endogenous Wnt regulatory response underlying the expression of these
essential regulators of kidney development. Although each tested region was selected for co-
binding to Six2 in nephron progenitors, the reporter gene expression was turned on after
Six2 is downregulated and Six2 is not required for the inductive response but for
suppression of inductive activity (Self et al., 2006); thus, Six2 binding correlates with
inactivity of these CRMs. Six2 is known to associate with members of groucho family of
transcriptional repressors (Lopez-Rios et al., 2003). While none of the individual elements
precisely replicated expression of the target gene, additional Six2 and β-catenin binding sites
flanking each target gene are predicted to contribute to the overall transcriptional output.
Six2 and β-catenin directly regulate the CM-specific expression of Six2 and Eya1
Six2 is auto-regulated through a proximal enhancer; the Six2 binding region in this enhancer
was recovered in the Six2 ChIP-seq data set but no co-association of β-catenin was observed
at this site (marked by ** in Figure 5A, Brodbeck et al., 2004; Kuure et al., 2007).
Interestingly, when the down-regulation of Six2 was compared in FACS isolated Six2+ cells
cultured for 24 hrs in DMSO or BIO, loss of Six2 expression was enhanced by Wnt pathway
activation (Figure 1B and data not shown). We identified a region 60 kb upstream of the
Six2 TSS that co-bound Six2 and β-catenin at multiple sites over a highly conserved, 1.1 kb
block of DNA and we examined the potential regulatory role of this region in transgenic
mice (Figure 5A and 5C). Reporter expression was very precisely directed to the
endogenous Six2 expression domain (Figure 5E and 5G). Despite the presence of multiple β-
catenin binding peaks, only one Lef/Tcf binding site was predicted in the enhancer (Figure
5C) and the mutation of this site did not alter transgene activity. Thus, the interaction of β-
catenin at this Six2 enhancer correlates with the downregulation of Six2 expression but not
through a direct Lef/Tcf factor-mediated DNA binding mechanism (Figure 5E).
Alignment of other recovered motifs indicated a close correlation of the recovered Tbp/Hox
motif and the predicted peak centers for β-catenin and Six2 binding (Figure 5C). This
observation suggests that Hox proteins, rather than Lef/Tcf factors or Six2 itself, may
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mediate regulatory inputs within the identified enhancer region. Interestingly, Hoxa11,
Hoxc11, and Hoxd11 play a combinatorial role in kidney development and Six2 expression
is lost when all three of these paralogs are mutated (Wellik et al., 2002). In addition, Hox11
paralogs have been shown to regulate Six2 expression through the proximal enhancer where
we detected Six2 binding (Gong et al., 2007; Yallowitz et al., 2009). Thus, Hox proteins
may serve as binding partners for Six2, and possibly for β-catenin, to regulate expression of
Six2. Consistent with this view, mutation of all predicted Tbp/Hox motifs, in the context of
the 1.1 kb Six2 CRM, abolished expression of the reporter (Figure 5E). These results
suggest that binding of β-catenin to a Hox/Six2 complex at the distal Six2 enhancer
abrogates enhancer activity attenuating Six2 expression during nephron induction.
Eya and Six factors interact to regulate target gene expression (Ohto et al., 1999). Eya
factors do not bind DNA, but modify the activity of their Six partners (Rebay et al., 2005;
Jemc and Rebay, 2007). Eya1 displays similar expression to Six2 in the CM during kidney
development suggesting that Eya1 may modulate Six2 activity (Mugford et al., 2009). In
contrast to Six2, Eya1 is essential prior to ingrowth of the ureteric epithelium, a phenotype
resembling Six1 mutants (Xu et al., 1999; Xu et al., 2003). A later collaborative role for
Eya1 and Six2 in progenitor maintenance remains an open question. Whereas Six2 was
downregulated by canonical Wnt signaling, Eya1 was upregulated on BIO stimulation
relative to DMSO control samples at 24 hrs (Figure 1B and data not shown). These data
suggest that Wnt action may promote nephron progenitor maintenance through Eya1.
The large number of Six2 and β-catenin associated binding regions around the Eya1 locus
suggest a complex regulation by these two pathways. Our ChIP-seq data identified multiple
β-catenin and Six2 binding sites associate with Eya1 upstream of the TSS and in intronic
regions (Figure 5B), and two conserved regions co-associated with β-catenin and Six2; one
in intron 9, the other 325 kb upstream of the Eya1 TSS. The potential regulatory action of
the - 325kb region was examined in transgenic kidneys: although transgenics displayed
mosaic expression, reporter expression was restricted to the Six2/Eya1 co-expressing CM
(Figure 5F and 5H). The mutation of predicted Lef/Tcf motifs in this enhancer did not alter
transgene expression (data not shown). Thus, β-catenin action at this distant enhancer
element is not consistent with a canonical Wnt transcriptional response in which β-catenin
association would depend on DNA binding of Lef/Tcf transcriptional partners.
Eya1 is one member of a group of genes predominantly expressed in the CM that are
associated with β-catenin and Six2 binding regions, whose expression is maintained in
cultured Six2+ cells through a BIO-dependent mechanism (Tables 1, S1, and S3).
Transcriptional profiling of Six2 and Wnt9 mutant kidneys has also identified a number of
genes positively regulated by both Six2 and Wnt9b input at the outset of kidney
development (Karner et al., 2011): among these, Itga8 and Fam19a5 were identified in our
ChIP-seq studies examining the E16.5 kidney. Collectively, our data indicate that Wnt
signaling plays an active role in supporting nephron progenitor specific programs of gene
regulation through a non-canonical mechanism with regard to β-catenin association at target
sites (e.g. Eya1), and through a classic Lef/Tcf dependent canonical DNA association in the
commitment of nephron progenitors (e.g. Wnt4 and Fgf8).
The Eya1 regulatory grouping - expression potentially enhanced by Six2 and β-catenin - is
unlikely to reflect a homogeneous regulatory response. Whereas, Hoxb4 (Preger-Ben Noon
et al., 2009; Dressler, 2009) and Gdnf (Sánchez et al., 1996; Pichel et al., 1996; Moore et al.,
1996) show similar trends to Eya1 in our microarray and DNA binding studies, transgenic
reporter assays analyzing conserved regions co-associated with Six2 and β-catenin showed
that transgene expression was restricted to distal regions of the RV-derivative (Figure S4).
Interestingly, Gdnf is the major signal regulating branching growth of the ureteric
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epithelium, the tissue source of the Wnt9b inductive signal: normal levels of GDNF
expression depend on a reciprocal interaction with Wnt11 secreted at the ureteric tips
(Majumdar et al, 2003). Classical experiments have long postulated a feedback in which
nephron induction stimulates branching (Saxén, 1987). Our data suggest a Wnt pathway-
specific regulatory input into Gdnf within newly induced cells consistent with a feedback
response. The domain of transgene expression more closely resembles other aspects of a
Wnt9b response, though a potential regulatory input by Wnt11 cannot be ruled out.
Six2 and HoxA11 can complex with β-catenin and each other
To further investigate the molecular mechanism of Six2 action, we examined the interaction
of Six2 with β-catenin in nephron progenitor cells. As we show in Figures 4D and 4E, a low
level of Six2 is present in early, differentiating nephron progenitors. Consequently, loss of
Six2 is not essential for commitment of nephron progenitors (see discussion) and the Six2
population is heterogeneous containing a minor fraction of early-induced cells. In contrast,
recent data indicates that Cited1 marks a subpopulation of Six2+ cells that consists of
undifferentiated cells (Mugford et al., 2009; Figure S5; see also www.gudmap.org for a
more extensive characterization). Interestingly, immunoprecipitation with anti-Six2
antibodies pulled down β-catenin in Six2+ cells isolated by FACS but not in the Cited1+
subset of the Six2+ population (Figure 6A). Thus, Six2 and β-catenin form a complex in
vivo consistent with the overlap in their DNA association in ChIP studies. However, this
complex appears to be restricted to the Wnt-induced population of committed nephron
progenitors (Six2+Cited1-cells).
The interaction between Six2 and β-catenin was explored in more detail in Wnt responsive
HEK293 kidney cells (Figure 6B-C). Immunoprecipitation of myc-tagged Six2 pulled down
FLAG-tagged Tcf4B independent of BIO-stimulation: thus, Six2 and Tcf4B form a complex
in the absence of canonical Wnt signaling (Figure 6B, lanes 6 and 7). In contrast, Six2 pull-
down of β-catenin was Tcf4B dependent (Figure 6B, lanes 7 and 8) while Tcf4B association
with Six2 or β-catenin was independent of the other factor (Figure 6C, lanes 6-8). Further,
whereas BIO stimulation resulted in a large increase in β-catenin association with Tcf4B as
expected, Six2 binding to Tcf4B was largely unaltered (Figure 6C, lanes 6-8). Given the
prediction of Hox-binding sites, and known role of Hox11 paralogs in kidney development,
we also examined potential interactions amongst HoxA11, Tcf4b, Six2 and β-catenin. In
HEK 293 cells, Six2 can interact with HoxA11 (Figure 6D) and with β-catenin in the
presence of Tcf4B (Figure 6E). Collectively, these data suggest that co-binding of Six2 and
β-catenin at CRMs in vivo is mediated, at least in part, through a common interaction with
Lef/Tcf family members. Further, Six2 does not compete with β-catenin for binding to a
common Tcf binding partner. Finally, Hox11 members are likely interacting partners in
aspects of the regulatory programs. Unfortunately, the absence of suitable antibodies
precluded analysis of potential interactions between Hox11 paralogs and β-catenin
containing complexes in the metanephric mesenchyme.
DISCUSSION
All stem/progenitor cell based systems must balance the maintenance of stem/progenitor cell
types and their commitment to differentiated components of the mature organ. Utilizing an
ex vivo inductive system, and intersecting transcriptional profiling data of Wnt response with
genomic analysis of Six2 and β-catenin bound DNA targets, our study provides a
comprehensive insight into the gene regulatory networks underpinning maintenance and
commitment of nephron progenitors.
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Gene regulation mediated by Six2 and β-catenin
A moderate number of target regions, 500-1,500 associate with, and likely mediate, the
transcriptional actions of Six2 and β-catenin. Most regions are associated with one factor,
but given evidence for opposing regulatory actions of the Six2 and Wnt pathway, our
analysis focused on a smaller set of shared binding regions, and their putative target genes.
We provide evidence for three distinct classes of transcriptional program amongst shared
targets of Six2 and β-catenin transcriptional networks (Table 1).
Class I genes are induced by canonical Wnt signaling in differentiating RVs (Figure 7).
Amongst this group are genes such as Fgf8 and Wnt4 encoding critical downstream
regulatory signals that are essential for nephrogenesis. Class I genes require β-catenin
activity in a canonical Lef/Tcf regulatory partnership at target sites (Park et al., 2007). Class
I targets are silent in uninduced CM cells where Six2 is bound at target sites. Six2 binding
likely reflects endogenous Six2/Lef/Tcf complexes from our analysis of protein-protein
interactions in vitro. The simplest model is one in which Six2 binding to Lef/Tcf factors in
the CM ensures that β-catenin is unable to broadly activate targets of the nephrogenic
inductive response throughout the CM (Figure 7). Interestingly, cell culture and in vivo
studies indicate that this is unlikely to reflect a competitive role for Six2 and β-catenin
binding to a Tcf factor. Instead, the association of both Six2 and Lef/Tcf factors with
groucho repressors (Arce et al., 2009; Lopez-Rios et al., 2003) suggests Six2 and Lef/Tcf
factors may cooperate to silence early drivers of nephrogenesis. A more precise definition of
this regulatory process will require improved Lef/Tcf antibodies with broad specificity
recognizing all isoforms.
Six2+ cells are targeted by the Wnt9b-directed nephron inducing response. Further, Six2 is
transiently present within cells that have activated Wnt4. Thus, the presence of Six2 is
clearly not sufficient to prevent some cells from responding to Wnt9b. Rather, Six2 action
likely ensures that at each round of induction, only a fraction of the potential progenitor pool
undergoes a commitment to nephrogenesis. Consequently, the loss of Six2 function leads to
all progenitor cells rapidly and quantitatively committing to a RV fate, through a Wnt9b-
dependent mechanism (Self et al., 2006; Kobayashi et al., 2008). Together these findings
imply a normal process that uncouples the inhibitory input of Six2 to enable a Wnt9b
inductive process. One possible mechanism could be the level of Wnt9b signaling. Earlier
work demonstrated close cellular contact was required between CM and Wnt9b producing
cells to invoke a RV inductive response (Carroll et al., 2005), consistent with a high-
threshold dependence for this inductive interaction. Once engaged, Wnt4 directed canonical
Wnt signaling would be expected to act as a rapid feed-forward mechanism at an early stage
in the RV induction process (Park et al., 2007).
Class II genes, represented by Six2 itself, are predominantly active in CM and
downregulated by Wnt input in the inductive process. Our data identifies a distal enhancer
for Six2 that mirrors the activity of a proximal regulatory element in driving reporter gene
activity to the Six2 population much like the shadow enhancers recently described around
many key developmental regulatory genes in Drosophila (Perry et al., 2010). Interestingly,
the association of β-catenin at the distal but not the proximal enhancer correlates with the
enhanced suppression of Six2 expression on Wnt9b mediated initiation of nephrogenesis
suggesting that the presence of β-catenin within this regulatory complex attenuates Six2
transcription. Given the strong association of β-catenin with the activation of transcription, it
is unlikely β-catenin is acting directly to recruit repressor factors but rather its presence
within this complex may interfere with a Six2-directed activating response.
Class III genes show similar expression to Six2 in the undifferentiated CM but are positively
regulated by Wnt signaling. Many of the genes identified in this category at the
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transcriptional level correspond with those displaying a dual requirement for Six2 and β-
catenin at the outset of kidney development (Karner et al., 2011; Table S1). However, we
see relatively little evidence of co-binding of Six2 and β-catenin around most of these genes.
Thus, their regulation may reflect indirect regulatory responses that are themselves
dependent on Six2 and β-catenin. In contrast, Eya1 displays a Class III regulatory pattern in
the E16.5 kidney progenitors but not at E11.5 (Karner et al., 2011) and the intersection of
Six2 and β-catenin binding predicts an enhancer with CM activity. Thus, co-regulatory
positive inputs through Six2 and β-catenin most likely maintain essential gene regulatory
programs in nephron progenitors
The finding that Six2 and β-catenin have opposing actions in the regulation of class I and II
genes, but act cooperatively in maintaining class III gene activity raises an interesting
question as to how these distinct regulatory actions are carried out. Analysis of target sites
suggests distinct DNA-regulatory complex interactions: enhancers for Class I targets are
predicted to be directly engaged through DNA binding by Lef/Tcf factors while those at
Eya1 are postulated to utilize a distinct DNA-binding component. Thus, different protein
complexes may guide distinct regulatory outputs to a β-catenin input. A continued focus on
the regulatory mechanisms acting on the enhancers identified in the current work is expected




The Six2TGC BAC transgenic was described previously (Kobayashi et al., 2008). In this
strain, a GFP∷CRE fusion gene is expressed under the control of Six2 regulatory regions.
Characterization of the Cited1-nuc-TagRFP-T BAC transgenic is available at http://
gudmap.org.
Fluorescence activated cell sorting (FACS)
E16.5 kidneys from Six2TGC+ or Cited1-nuc-TagRFP-T+ embryos were trypsinized,
dissociated by repetitive pipetting, and resuspended in PBS containing 2% FBS and 10mM
EDTA. The resuspended cells were filtered through 40 μm Nylon Cell Strainer (BD Falcon)
and kept on ice until FACS. The GFP+ or RFP+ cells were isolated using Dako cytomation
MoFlo.
In vitro culture and transcriptional profiling of nephron progenitor cells
The FACS isolated Six2+ cells (about 40,000 cells per sample) were aggregated by
centrifugation at 800 × g for 5 min and cultured in 10% FBS/DMEM in the presence of 4
μM BIO or DMSO. After 24 hrs, the media was changed as indicated. RNA from three
biological replicates under each experimental condition was isolated by using Absolutely
RNA Nanoprep kit (Stratagene) and amplified by using TargetAmp 2-Round Biotin-aRNA
Amplification kit 3.0 (Epicentre). The biotinylated probes were hybridized to GeneChip
Mouse Genome 430 2.0 (Affymetrix). The raw microarray data were processed and
normalized using dChip (Li and Wong, 2001).
ChIP-seq analysis
ChIP was performed as previously described with some modification (Vokes, et al. 2007). A
detailed procedure is provided in Supplemental Data.
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Each of the putative enhancer regions was cloned into p2xINS-Hsp68-lacZ (Vokes et al.,
2007) or p2xINS-HSP68-GFPcre. In these constructs, a putative enhancer was inserted
downstream of two copies of the chicken β-globin insulator and upstream of Hsp68 minimal
promoter-driven β-galactosidase or GFPcre. The entire expression cassette was purified by
electroelution. Pronuclear injections were performed at Harvard Genome Modification
Facility. The embryos were harvested at E15.5. In the case of p2xINS-Hsp68-lacZ, the
kidneys were stained with X-gal, fixed in 4% PFA/PBS, cleared in 80% glycerol/PBS, and
photographed using a Nikon SMZ 1500 fluorescent microscope. In the case of p2xINS-
HSP68-GFPcre, the kidneys were photographed using a Nikon Eclipse 90i epi-fluorescent
microscope.
In situ hybridization
E15.5 kidneys were fixed in 4%PFA/PBS at 4°C overnight and dehydrated in methanol.
Hybridized samples were developed in BM purple (Roche), cleared in 80% glycerol/PBS,
and photographed using a Nikon DXM1200 digital camera.
Immunofluorescence
Embryonic kidneys were obtained from transgenic lines carrying p2xINS-Hsp68-lacZ or
from G0 transgenic embryos carrying p2xINS-HSP68-GFPcre. E15.5 kidneys or in vitro
cultured nephron progenitor cells were fixed in 4% PFA/PBS, incubated in 20% sucrose/
PBS at 4°C overnight, and imbedded in OCT. 12 μm sections were incubated overnight with
5% heat inactivated sheep serum/PBST containing primary antibodies against E-cadherin
(rat, 1:1000, Sigma) β-galactosidase (rabbit, 1:15000, MP bio or mouse IgG2a, 1:1000,
Promega), GFP (chick, 1:500, AvesLabs), cytokeratin (mouse IgG1, 1:200, Sigma), Jag1
(rat, 1:20, DSHB), Six2 (rabbit, 1:500, Proteintech). The secondary antibodies were
conjugated with Cy2 (chick), Alexa 488 (rat or mouse IgG2a), Alexa 555 (rabbit), Alexa
568 (rat), or Alexa 633 (rat or mouse IgG1). Nuclei were stained with Hoechst 33342
(Invitrogen) before mounting. Confocal images were acquired on a Zeiss 710 inverted
confocal microscope.
Pull down assay
The nuclear extracts of FACS isolated cells were incubated with Dynabeads (Invitrogen)
coupled with either normal rabbit antibody or Six2 antibody (Proteintech) at 4°C for
overnight. The beads were washed four times with TBS containing 0.25% TX-100. HEK293
cells were transfected with plasmids as indicated. After 24 hrs of transfection, cells were
treated with either 4 μM of BIO or DMSO as indicated. Additional 24 hrs later, cells were
lysed in lysis buffer (50mM HEPES, pH7.5, 140mM NaCl, 1mM EDTA, 0.5% NP-40,
0.25% TX-100, 1x complete mini protease inhibitor (Roche)). Lysates were incubated with
anti-myc antibody (9E10, DSHB) coupled dynabeads at 4°C for overnight. The beads were
washed three times with lysis buffer. The western blot was performed with anti-Six2
antibody (Proteintech), anti-FLAG antibody (M2, Sigma), anti-myc antibody (Cell Signaling
Technology), or anti β-catenin (Cell Signaling Technology) antibodies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Identification of gene regulatory networks in nephron progenitors
• Maintenance and commitment pathways integrated at cis-regulatory modules
• Multiple roles for β-catenin complexes in progenitor programs
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Figure 1. Transient activation of canonical Wnt signaling induces nephron progenitors to
undergo a mesenchymal-to-epithelial transition
(A) Aggregated Six2-GFP+ nephron progenitors were incubated for 24 hrs with either BIO
or DMSO (vehicle) and further incubated for an additional 24 hrs with either BIO or DMSO.
(B) Transcriptional profiles of nephron progenitors after activation of canonical Wnt
signaling under dispersed or aggregated culture conditions. Aggregated nephron progenitors
were exposed to either transient activation (B➔D, 24 hrs with BIO followed by another 24
hrs without BIO) or constitutive activation of canonical Wnt signaling (B➔B, 24 hrs with
BIO and another 24 hrs with BIO).
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Figure 2. Peak Statistics, Motif Analyses and GREAT annotations of β-catenin and Six2 ChIP-
seq datasets
(A) Venn-diagram of the overlap between β-catenin (orange circle) and Six2 (green circle)
bound ChIP products with a 0.01 FDR cutoff.
(B) Density graph of the peak locations in relation to the nearest transcriptional start sites
(TSS). X-axis represents distance from the peak center to the nearest TSS, where 0 is the
position of the TSS. Y-axis represents proportion of detected bindings that are located
within each distance interval (distance increasing at 10 kb intervals). Orange line, β-catenin
peaks; Green line, Six2 peaks.
(C) Top five enriched de novo motifs recovered from ChIP-seq peak regions. Separate runs
of de novo motif discovery were performed on genomic regions bound by β-catenin, Six2, or
both. The motif logos display nucleotide frequencies (scaled relative to the information
content) at each position. The horizontal bars on the right side represent the motif
enrichment in peak regions (r3, defined in Supplemental Experimental Procedures). For each
motif, we calculate its enrichment in five different sets of peak regions: β-catenin peak
regions (orange bar), Six2 peak regions (green bar), common peak regions (purple bar), β-
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catenin distinctive peak regions (orange shadowed bar) and Six2 distinctive peak regions
(green shadowed bar). N/A, not applicable.
(D) De novo motif occupancies in β-catenin peak regions. The blue bars are for the peaks
containing de novo Lef/Tcf motif sites.
(E) De novo motif occupancies in Six2 peak regions. The pink bars are for the peaks
containing de novo Six2 motif sites.
(F) MGI expression annotations of β-catenin, Six2 and common peaks analyzed by GREAT.
A sample of 11 representative annotations are shown for each peak category. Histogram
represents the –log10 (binomial p-value) for each annotation.
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Figure 3. Identification of common interaction sites for Six2 and β-catenin adjacent to genes
encoding key nephrogenic regulatory factors
(A-F) Binding of Six2 and β-catenin viewed in the CisGenome Browser (Jiang et al., 2010)
within the indicated genomic intervals (mm9 coordinates). ChIP product sequences on
Watson and Crick strands are shown in red and blue; binding sites are predicted to be at the
intersection of these peaks. Input control represents sequencing data of chromatin that was
not subjected to immunoprecipitation. IgG control represent sequencing data from mock
immunoprecipitates with rabbit IgG. Conservation denotes placental mammal basewise
conservation by Phastcons score. Lef/Tcf motif predictions are displayed; overlap with
conserved DNA regions is indicated in red and non-conserved regions in black. Putative
CRMs tested in transgenic analyses (Figure 4) are marked by asterisks (*) in A, C, and E
(global view) and by a red underline in B, D, and F (viewed in higher magnification). The
peak marked by ** in (A) is an artifact detected in both Input and IgG controls. The β-
catenin peak marked by ** in (C) was tested in transgenic analysis but no expression of the
reporter was observed in kidneys of the transgenic embryos. The Six2 bound region
downstream of Fgf8 showed statistically significant association of Six2 in only one
biological replicate.
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Figure 4. Transgenic validation of cis-regulatory modules associated with nephrogenic
determinants that are co-bound by Six2 and β-catenin
(A-C) Whole mount in situ hybridization detects expression of endogenous genes (left
panels). β-galactosidase activity of transgenic reporter driven by the putative CRMs
identified through Six2 and β-catenin co-binding (middle panels). β-galactosidase activity
driven by the CRMs with mutated Lef/Tcf binding sites (right panels). The ratio indicates
the number of embryos showing the illustrated expression pattern over the total number of
transgenic progeny, each from a unique founder. (D-G) Expression of Six2 and Jag1 in the
pretubular aggregate (AG), renal vesicle (RV), comma-shaped body (CSB), and S-shaped
body (SSB) stages of nephrogenesis in the mammalian kidney. The AG and RV are shown
divided into the distal and proximal parts by a white dashed line. Jag1 is expressed in the
lumen of AG, at the distal part of RV, and at the medial segment of SSB. Six2 is expressed
in undifferentiated nephron progenitors and downregulated in AG and RV. Cytokeratin
(CK) marks the ureteric epithelium. (H-M) Expression of reporters driven by CRMs co-
bound by Six2 and β-catenin in E15.5 transgenic kidneys.
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Figure 5. Six2 and Eya1 genes are common targets of Six2 and β-catenin
(A-B) Binding of Six2 and β-catenin in genomic intervals containing Six2 (A) and Eya1 (B).
Putative CRMs tested in transgenic analyses (E-H) are marked with asterisks (*). (C) De
novo motifs found in Six2 enhancer. Tbp/Hox motifs, rather than Lef/Tcf motif, were found
to center on peaks of Six2 and β-catenin binding. (D) Putative CRM upstream of the Eya1
gene tested in transgenic analysis (shown in (F)) is underlined in red. (E) G0 transgenic
analysis of Six2 enhancer. Endogenous expression of Six2 is shown on the left. Images of β-
galactosidase expression driven by the Six2 enhancer (Six2e-lacZ) and by the Six2 enhancer
carrying a mutated Tcf motif (TCFmut-lacZ) are shown in the middle. Expression of β-
galactosidase driven by the Six2 enhancer carrying quadruple mutations of Tbp/Hox motifs
(HOXqmut-lacZ) is shown on the right. (F) G0 transgenic analysis of Eya1 enhancer. (G)
Expression of the transgenic reporter driven by Six2 enhancer. Note Six2 enhancer
recapitulates expression of endogenous Six2. Endogenous Six2 (green) is localized in nuclei
and β-galactosidase driven by Six2 enhancer cassette is present throughout the cell. (H)
Expression of the reporter driven by putative Eya1 enhancer. Eya1 enhancer shows mosaic
expression in a restricted domain that overlaps with endogenous Six2.
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Figure 6. Six2 interacts with β-catenin, Tcf4, and HoxA11
(A) Six2 interacts with β-catenin. Immunoprecipitation of Six2 was performed with nephron
progenitors isolated from either Cited1-RFP+ or Six2-GFP+ embryonic kidneys and
analyzed by Western blot to detect β-catenin. (B) Six2 forms a ternary complex with Tcf4B
and β-catenin. HEK293T cells were transfected with plasmids as indicated. BIO was added
to induce accumulation of β-catenin. Lysates were immunoprecipitated with anti-myc
antibody and analyzed by Western blot to detect proteins as indicated. (C) Six2 and β-
catenin do not compete for binding to Tcf4B. (D) Six2 interacts with HoxA11. (E) HoxA11
forms a complex with β-catenin in the presence of Tcf4B.
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Figure 7. Regulation of class I genes by Six2 and β-catenin in nephron progenitors
In undifferentiated nephron progenitors (Cited1+ cells), Six2/Lef/Tcf complexes prevents β-
catenin from activating class I genes, such as Fgf8 and Wnt4. In differentiating nephron
progenitor cells, a high dosage of Wnt9b activates class I genes by elevating β-catenin level
and lowering Six2 level.
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